News from AACR 2024: Sunday’s highlights
Drug Discovery World
APRIL 8, 2024
Ichnos Glenmark Innovation Ichnos Glenmark Innovation (IGI), an alliance between Ichnos Sciences and Glenmark Pharmaceuticals, shared pre-clinical data for its oncology asset ISB 2001, which is currently being tested in a Phase I clinical trial in relapsed/refractory multiple myeloma (r/r MM).
Let's personalize your content